Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/212288
COMPARTIR / EXPORTAR:
logo share SHARE logo core CORE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE

Invitar a revisión por pares abierta
Título

Predictors of mortality in solid organ transplant recipients with bloodstream infections due to carbapenemase-producing Enterobacterales: The impact of cytomegalovirus disease and lymphopenia

AutorPérez-Nadales, Elena; Gutiérrez-Gutiérrez, Belén CSIC ORCID; Natera, Alejandra M.; Abdala, Edson; Reina Magalhães, Maira; Mularoni, Alessandra; Monaco, Francesco; Camera Pierrotti, Ligia; Pinheiro Freire, Maristela; Iyer, Ranganathan N.; Mehta Steinke, Seema; Grazia Calvi, Elisa; Tumbarello, Mario; Falcone, Marco; Fernández-Ruiz, Mario; Costa-Mateo, Jose M.; Rana, Meenakshi M.; Mara Varejao Strabelli, Tania; Paul, Mical; Fariñas, María del Carmen; Trindade Clemente, Wanessa; Roilides, Emmanuel; Muñoz García, Patricia; Dewispelaere, Laurent; Loeches, Belén; Lowman, Warren; Hock Tan, Ban; Escudero-Sánchez, Rosa; Bodro, Marta; Grossi, Paolo Antonio; Soldani, Fabio; Gunseren, Filiz; Nestorova, Nina; Pascual, Álvaro CSIC ORCID; Martínez-Martínez, Luis; Aguado, José María; Aguado, José María; Torre-Cisneros, Julián
Palabras claveAntibiotic drug resistance
Clinical research/practice
Infection and infectious agents - bacterial
Infectious diseases
Organ transplantation in general
Fecha de publicaciónjun-2020
EditorJohn Wiley & Sons
CitaciónAmerican Journal of Transplantation 20(6): 1629-1641 (2020)
ResumenTreatment of carbapenemase‐producing Enterobacterales bloodstream infections in solid organ transplant recipients is challenging. The objective of this study was to develop a specific score to predict mortality in solid organ transplant recipients with carbapenemase‐producing Enterobacterales bloodstream infections. A multinational, retrospective (2004‐2016) cohort study (INCREMENT‐SOT, ClinicalTrials.gov NCT02852902) was performed. The main outcome variable was 30‐day all‐cause mortality. The INCREMENT‐SOT‐CPE score was developed using logistic regression. The global cohort included 216 patients. The final logistic regression model included the following variables: INCREMENT‐CPE mortality score ≥8 (8 points), no source control (3 points), inappropriate empirical therapy (2 points), cytomegalovirus disease (7 points), lymphopenia (4 points), and the interaction between INCREMENT‐CPE score ≥8 and CMV disease (minus 7 points). This score showed an area under the receiver operating characteristic curve of 0.82 (95% confidence interval [CI] 0.76‐0.88) and classified patients into 3 strata: 0‐7 (low mortality), 8‐11 (high mortality), and 12‐17 (very‐high mortality). We performed a stratified analysis of the effect of monotherapy vs combination therapy among 165 patients who received appropriate therapy. Monotherapy was associated with higher mortality only in the very‐high (adjusted hazard ratio [HR] 2.82, 95% CI 1.13‐7.06, P = .03) and high (HR 9.93, 95% CI 2.08‐47.40, P = .004) mortality risk strata. A score‐based algorithm is provided for therapy guidance.
Versión del editorhttps://doi.org/10.1111/ajt.15769
URIhttp://hdl.handle.net/10261/212288
DOI10.1111/ajt.15769
Identificadoresdoi: 10.1111/ajt.15769
e-issn: 1600-6143
issn: 1600-6135
Aparece en las colecciones: (IBIS) Artículos




Ficheros en este ítem:
Fichero Descripción Tamaño Formato
accesoRestringido.pdf15,38 kBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro completo

CORE Recommender

SCOPUSTM   
Citations

21
checked on 13-mar-2024

WEB OF SCIENCETM
Citations

18
checked on 25-feb-2024

Page view(s)

687
checked on 19-mar-2024

Download(s)

60
checked on 19-mar-2024

Google ScholarTM

Check

Altmetric

Altmetric


NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.